Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
New reporting items and recommendations for randomized trials impacted by COVID- 19 and force majeure events: a targeted approach
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting of randomised clinical trials impacted by COVID-19 and force majeure events. |
| Full bibliographic reference | Leung TH, Ho JC, El Helali A, Vokes EE, Wang X, Pang H. New reporting items and recommendations for randomized trials impacted by COVID-19 and force majeure events: a targeted approach. Ann Transl Med.2023;11(1):2. |
| Language | English |
| PubMed ID | 36760246 |
| Study design | Clinical trials, Experimental studies |
| Applies to the whole report or to individual sections of the report? | Abstract, Harms/adverse effects/safety data, Intervention (exposure), Narrative sections (discussion etc.), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) |
| Record last updated on | May 16, 2023 |